Skip to main content

Find Clinical Trials

Home
Conditions
Immunoproliferative Disorders

Clinical trial condition

Immunoproliferative Disorders

Explore clinical trials studying Immunoproliferative Disorders. Study availability and eligibility vary by location and protocol.

9,965 public trials 2,022 recruiting studies

Refine in advanced search Browse all conditions

Immunoproliferative Disorders trial results

Completed

Safety and Tolerability of Rilonacept in Muckle-Wells Syndrome (MWS) or Schnitzler Syndrome (SchS)

NCT01045772

Conditions: Chronic Disease, Chronic Inducible Urticaria, Chronic Urticaria, +21 more
Locations: Charité University Hospital Berlin, State of Berlin, Germany

View Trial Details

Completed

Tocladesine in Treating Patients With Recurrent or Refractory Multiple Myeloma

NCT00004902

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +13 more
Locations: Robert H. Lurie Comprehensive Cancer Center, Northwestern University Chicago, Illinois, United States

View Trial Details

Completed

Tretinoin in Treating Patients With Mycosis Fungoides or Sezary Syndrome

NCT00002479

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +8 more
Locations: Robert H. Lurie Comprehensive Cancer Center, Northwestern University Chicago, Illinois, United States

View Trial Details

Completed

Cellular Therapy With Cord Blood Cells

NCT00427557

Conditions: Blood Protein Disorders, Bone Marrow Diseases, Cardiovascular Diseases, +30 more
Locations: UT MD Anderson Cancer Center Houston, Texas, United States

View Trial Details

Completed

Efficacy and Safety of Canakinumab in Schnitzler Syndrome

NCT01276522

Conditions: Immune System Diseases, Immunoproliferative Disorders, Monoclonal Gammopathy of Undetermined Significance, +2 more
Locations: Radboud University Nijmegen Medical Centre Nijmegen, Netherlands

View Trial Details

Completed

Second Malignant Neoplasms After Childhood ALL Therapy

NCT01476462

Conditions: Acute Lymphoblastic Leukemia, Hematologic Diseases, Hemic and Lymphatic Diseases, +10 more
Locations: Kjeld Schmiegelow Copenhagen, Denmark

View Trial Details

Completed

Samsung Medical Center-Lymphoma Cohort Study

NCT00822731

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +5 more
Locations: Samsung Medical Center Seoul, South Korea

View Trial Details

Completed

Treatment of Chronic Lymphocytic B-Leukemia With IL-2 and CD-40 Autologous Tumor Cells

NCT00058786

Conditions: Chronic Disease, Chronic Lymphocytic B-Leukemia, Disease Attributes, +14 more
Locations: The Methodist Hospital Houston, Texas, United States

View Trial Details

Completed

Epstein-Barr Virus (EBV)-Specific T Cells as Therapy for Relapsed/Refractory EBV-positive Lymphomas

NCT00779337

Conditions: DNA Virus Infections, Epstein-Barr Virus Infections, Hemic and Lymphatic Diseases, +11 more
Locations: Princess Alexandra Hospital Brisbane, Queensland, Australia

View Trial Details

Completed

A Multicentre, Single-arm, Open-label Safety Study of Lenalidomide Plus Dexamethasone in Previously Treated Subjects With Multiple Myeloma

NCT00420849

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations: The Mater Private Centre for Haematology & Oncology South Brisbane, Australia

Wilhelminenspital Vienna, Montlearstrasse 37, Austria

St James's Hospital Dublin, Ireland

H. Clínico de Salamanca Salamanca, Spain

View Trial Details